Literature DB >> 29446454

Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis.

Amanda F Nahhas1, Mohsin Alam2, Henry W Lim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29446454     DOI： 10.1111/ijd.13940

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

1.  Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab.

Authors:  Nicolás Jiménez-García; Josefa Aguilar-García; Inés Fernández-Canedo; Nuria Blázquez-Sánchez; Rafael Fúnez-Liébana; Carlos Romero-Gómez
Journal:  Rheumatol Int       Date:  2021-01-23       Impact factor: 2.631

2.  Eosinophilic Fasciitis - Report of Three Cases and Review of the Literature.

Authors:  Uwe Wollina; Gesina Hansel; Jacqueline Schönlebe; Birgit Heinig; Ivanka Temelkova; Georgi Tchernev; Aleksandra Vojvocic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-05-15

Review 3.  Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature.

Authors:  Daniel Erez; Yehuda Shoenfeld; Ayman Natour; Zamir Dovrish; Oshrat E Tayer-Shifman; Yair Levy
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.